retatrutide glp-1 medication Retatrutide, a GIP, and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Lilly, with new data, to

By targeting receptors in the brain, GLP-1 incretin mimetics can decrease addictive cravings while improving overall cognitive function by lowering food noise

Additionally, longer-term data will also be necessary to determine how durable maintenance effects remain over multiple years

It helps by increasing your metabolism, building lean muscle, improving how your body handles insulin, and aiding in long-term weight management

It is also one of the most frustrating aspects of practicing obesity medicine

Muscle supports glucose disposal, mobility, balance, strength, metabolic flexibility, and long-term weight maintenance

The information provided on this site is for informational purposes only and should not be considered medical advice or a substitute for professional healthcare